A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia - Lancet, JE; Baer, MR; Duran, GE; List, AF; Fielding, R (Leuk Res., 2009)
Aug